Periodontal Disease – Market Outlook, Epidemiology, Competitive Landscape, and Market Forecast Report – 2022 To 2032

Periodontal disease activity is defined clinically by progressive loss of probing attachment and radiographically by progressive loss of alveolar bone. This disease, encompassing gingivitis, and periodontitis, exhibits high prevalence among adults, and its severity tends to increase with age. It is a bacterial infection primarily affecting the dental biofilm or plaque. Individual risk factors for periodontal disease can be categorized as follows: lifestyle factors such as gender, smoking, and alcohol; diabetes; obesity and metabolic syndrome; osteoporosis, dietary calcium, and vitamin D; stress; and genetic factors. The common signs and symptoms of periodontal disease include redness, swelling, and tenderness of the gums; bleeding during brushing and flossing; recession of the gums; loose or separating teeth; persistent halitosis; ill-fitting partial dentures; the presence of pus between the teeth and gums; and alterations in bite and jaw alignment. Periodontal disease is classified into different types based on disease stage, including gingivitis, mild periodontitis, and moderate to advanced periodontitis. Gingivitis represents the mildest form, characterized by red, swollen, and tender gums that bleed easily. Timely dental care and consistent home care can help resolve these issues. If left untreated, gingivitis progresses to mild periodontitis, where periodontal pockets form as the gums detach from the teeth, leading to early bone loss. Prompt dental intervention is necessary to prevent further bone erosion and gum damage. In the most advanced stage, moderate to advanced periodontitis, significant bone loss, deepening of periodontal pockets, and gum recession are observed. Extraction of teeth may be required due to tooth looseness. Treatment options for periodontal disease may include tartar and plaque removal below the gumline through deep cleaning (scaling and root planing), eliminating tartar and infected tissue in the early stages while smoothing damaged root surfaces to facilitate gum reattachment. Antibacterial medications can be applied topically in periodontal pockets or taken orally. In advanced cases, surgery may be necessary to clean infected areas beneath the gums and reshape or replace tissues.

·       Data indicate that 47.2% of adults aged 30 years and older have some periodontal disease. Moreover, its prevalence increases with age, with 70.1% of adults aged 65 years and older affected.

·       This condition exhibits higher occurrence among men compared to women (56.4% vs. 38.4%), individuals living below the federal poverty level (65.4%), those with less than a high school education (66.9%), and current smokers (64.2%).

Thelansis’s “Periodontal Disease Market Outlook, Epidemiology, Competitive Landscape, and Market Forecast Report – 2022 To 2032" covers disease overview, epidemiology, drug utilization, prescription share analysis, competitive landscape, clinical practice, regulatory landscape, patient share, market uptake, market forecast, and key market insights under the potential Periodontal Disease treatment modalities options for eight major markets (USA, Germany, France, Italy, Spain, UK, Japan, and China).

KOLs insights of Periodontal Disease across 8 MM market from the centre of Excellence/ Public/ Private hospitals participated in the study. Insights around current treatment landscape, epidemiology, clinical characteristics, future treatment paradigm, and Unmet needs.

Periodontal Disease Market Forecast Patient Based Forecast Model (MS. Excel Based Automated Dashboard), which Data Inputs with sourcing, Market Event, and Product Event, Country specific Forecast Model, Market uptake and patient share uptake, Attribute Analysis, Analog Analysis, Disease burden, and pricing scenario, Summary, and Insights.

Thelansis Competitive Intelligence (CI) practice has been established based on a deep understanding of the pharma/biotech business environment to provide an optimized support system to all levels of the decision-making process. It enables business leaders in forward-thinking and proactive decision-making. Thelansis supports scientific and commercial teams in seamless CI support by creating an AI/ ML-based technology-driven platform that manages the data flow from primary and secondary sources.

Read more: Periodontal Disease – Market Outlook, Epidemiology, Competitive Landscape, and Market Forecast Report – 2022 To 2032

 

Comments

Post a Comment

Popular posts from this blog

Acne Vulgaris – Market Outlook, Epidemiology, Competitive Landscape, and Market Forecast Report – 2022 To 2032

Image
  Acne vulgaris, a prevalent pilosebaceous unit inflammatory skin disorder, follows a persistent course. Typically presenting as papules, pustules, or nodules, it primarily occurs on the face but can also impact the upper arms, trunk, and back. The development of acne results from the sebaceous glands' heightened sensitivity to normal androgen levels, aggravated by Cutibacterium acnes (formerly known as Propionibacterium acnes), a bacterial species that triggers inflammation. The pathogenesis of acne vulgaris involves a complex interplay of factors such as the activation of sebaceous glands by androgens, imbalances in the pilosebaceous follicle microbiome, and cellular immune responses. Genetic predisposition and dietary influences also contribute to the condition's onset and progression. The initial stage is the micro-comedo, a small plug primarily composed of corneocytes in the lower follicular infundibulum. Microcomedones evolve into various acne lesions, including closed co...
Read more

Metabolic Syndrome – Market Outlook, Epidemiology, Competitive Landscape, and Market Forecast Report – 2023 To 2033

Image
  Metabolic syndrome refers to a clustering of multiple disorders that collectively increase an individual's susceptibility to atherosclerotic cardiovascular disease, insulin resistance, diabetes mellitus, as well as vascular and neurological complications such as cerebrovascular accidents. The underlying causes of metabolic syndrome typically include excess weight, obesity, a sedentary lifestyle, and genetic predisposition. This syndrome exerts detrimental effects on various body systems. Insulin resistance, a key component of metabolic syndrome, leads to microvascular damage, increasing the risk of endothelial dysfunction, vascular resistance, hypertension, and inflammation of vessel walls. Bariatric surgery is recognized as the most effective standalone therapy for metabolic syndrome. However, patients undergoing this procedure require long-term follow-up to mitigate potential surgical, nutritional, and psychiatric complications. Thelansis’s “Metabolic Syndrome Market Outl...
Read more

Type 1 Diabetes Mellitus (T1D) – Market Outlook, Epidemiology, Competitive Landscape, and Market Forecast Report – 2023 To 2033

Image
  Type 1 Diabetes Mellitus (T1D) is characterized as an autoimmune disorder resulting in the autoimmune destruction of insulin-producing pancreatic beta cells. This condition necessitates life-long insulin replacement, administered through multiple daily insulin injections, insulin pump therapy, or an automated insulin delivery system. The absence of insulin can lead to the development of Diabetic Ketoacidosis (DKA), a life-threatening condition. The most common symptoms associated with this disease are polyuria and polydipsia. Effective management of T1D involves: Multiple daily insulin injections Insulin pump therapy An automated insulin delivery system in conjunction with glucose monitoring Continuous Glucose Monitoring (CGM) is the preferred method. However, all individuals with T1D should be capable of performing Blood Glucose Monitoring (BGM) via capillary blood if CGM is not available. Acute complications of diabetes primarily include hypo...
Read more